Research & Literature

A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations.

Zhang H, Li S, Yang J, et al.

Przeglad gastroenterologiczny 2015; (10(3)):148-55 doi:10.5114/pg.2015.51187.

The clinical phenotypes of autoimmune hepatitis: A comprehensive review.

Wang Q, Yang F, Miao Q, et al.

Journal of autoimmunity 2016; (66()):98-107.

Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

de Boer YS, Kosinski AS, Urban TJ, et al.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017; (15(1)):103-112.e2 doi:10.1016/j.cgh.2016.05.043.

Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter.

Omori K, Yoshida K, Yokota M, et al.

Clinical journal of gastroenterology 2016; (9(5)):312-8 doi:10.1007/s12328-016-0676-1.

Innumerable Liver Masses in a Patient with Autoimmune Hepatitis and Primary Sclerosing Cholangitis Overlap Syndrome.

Gharibpoor A, Mansour-Ghanaei F, Sadeghi M, et al.

The American journal of case reports 2017; (18()):131-135 doi:10.12659/ajcr.901153.

Autoimmune Hepatitis Overlap Syndromes and Liver Pathology.

Czaja AJ, Carpenter HA

Gastroenterology clinics of North America 2017; (46(2)):345-364 doi:10.1016/j.gtc.2017.01.008.

Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.

Gossard AA, Gores GJ

Clinics in liver disease 2017; (21(4)):725-737 doi:10.1016/j.cld.2017.06.004.

Primary sclerosing cholangitis.

Dyson JK, Beuers U, Jones DEJ, et al.

Lancet (London, England) 2018; (391(10139)):2547-2559 doi:10.1016/S0140-6736(18)30300-3.

Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.

Yan X, Jin J

Medicine 2018; (97(8)):e0004 doi:10.1097/MD.0000000000010004.

Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.

Efe C, Taii HA, Ytting H, et al.

Digestive diseases and sciences 2018; (63(5)):1348-1354 doi:10.1007/s10620-018-5011-x.

Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.

Martínez Casas OY, Díaz Ramírez GS, Marín Zuluaga JI, et al.

Gastroenterologia y hepatologia 2018; (41(9)):544-552 doi:10.1016/j.gastrohep.2018.05.019.

Incidence and Clinical Features of Autoimmune Hepatitis in the Province of Santa Fe (Argentina).

Costaguta A, González A, Pochettino S, et al.

Journal of pediatric gastroenterology and nutrition 2018; (67(6)):e107-e110 doi:10.1097/MPG.0000000000002122.

Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study.

Fan X, Zhu Y, Men R, et al.

Canadian journal of gastroenterology & hepatology 2018; (2018()):1965492 doi:10.1155/2018/1965492.

Risk stratification and treatment of primary biliary cholangitis.

Martínez J, Aguilera L, Albillos A

Revista espanola de enfermedades digestivas 2019; (111(1)):63-70 doi:10.17235/reed.2018.5662/2018.

Primary sclerosing cholangitis: Unique aspects of disease in children.

Cotter JM, Mack CL

Clinical liver disease 2017; (10(5)):120-123 doi:10.1002/cld.672.

Effective treatment of autoimmune hepatitis-primary biliary cholangitis overlap syndrome with obeticholic acid.

Castro Limo JD, Romero-Gutiérrez M, Ruiz Martín J

Revista espanola de enfermedades digestivas 2020; (112(9)):737 doi:10.17235/reed.2020.6883/2020.

Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review.

Ballotin VR, Bigarella LG, Riva F, et al.

World journal of clinical cases 2020; (8(18)):4075-4093 doi:10.12998/wjcc.v8.i18.4075.

Performance of 2D-shear wave elastography in autoimmune hepatitis-primary biliary cholangitis overlap syndrome.

Wang X, Li Y, Jiang L, et al.

Abdominal radiology (New York) 2023; (48(4)):1290-1297 doi:10.1007/s00261-023-03840-1.

Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

Catanzaro E, Gringeri E, Burra P, Gambato M

Cancers 2023; (15(20)) doi:10.3390/cancers15204947.

Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome.

Graf M, Lange CM, Langer MM, et al.

Journal of clinical medicine 2023; (12(22)) doi:10.3390/jcm12227047.

Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood.

Warner S, Rajanayagam J, Russell E, et al.

JHEP reports : innovation in hepatology 2024; (6(2)):100901 doi:10.1016/j.jhepr.2023.100901.

Chronic Liver Disease, Not Everything Is What It Seems: Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome.

Rodrigues Barbosa B, Pereira L, Campante F, Pona AP

Cureus 2024; (16(1)):e51630 doi:10.7759/cureus.51630.

Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome.

Varadarajan A, Rastogi A, Maiwall R, et al.

Indian journal of pathology & microbiology 2024; (67(1)):107-114 doi:10.4103/ijpm.ijpm_72_22.

Editorial: Are changes in quantitative biliary metrics the first sign of progression in primary sclerosing cholangitis?

Eaton JE, Venkatesh SK

Alimentary pharmacology & therapeutics 2024; (59(12)):1630-1631 doi:10.1111/apt.17996.

Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review.

Souissi S, Laabidi S, Mustpha NB, et al.

Future science OA 2024; (10(1)):FSO971 doi:10.2144/fsoa-2023-0187.

The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants.

Bolis F, Cazzaniga G, Pagni F, et al.

Gastroenterologia y hepatologia 2025; (48(2)):502225 doi:10.1016/j.gastrohep.2024.502225.

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy.

Stoelinga AEC, Biewenga M, Drenth JPH, et al.

JHEP reports : innovation in hepatology 2024; (6(7)):101088 doi:10.1016/j.jhepr.2024.101088.

Paediatric-onset autoimmune liver disease: Insights from a monocentric experience.

Curci F, Rubino C, Stinco M, et al.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025; (57(2)):494-501 doi:10.1016/j.dld.2024.09.020.

Autoimmune Disorders of the Liver and Biliary Tract.

Anderson CM, Welle CL, Ludwig DR, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240126 doi:10.1148/rg.240126.

Clinical outcomes in patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome in the United States.

Goyal RM, Bansal B, Ayyad M, et al.

Clinics and research in hepatology and gastroenterology 2025; (49(6)):102598 doi:10.1016/j.clinre.2025.102598.

Lipofuscinosis as a novel discriminating feature for drug-induced liver injury from autoimmune hepatitis.

Weber S, Erhardt F, Neumann J, et al.

Scandinavian journal of gastroenterology 2025; 1-7 doi:10.1080/00365521.2025.2517207.

Double Trouble: Drug-Induced Autoimmune Hepatitis (AIH)-Primary Biliary Cholangitis (PBC) Overlap Syndrome Triggered by Hydralazine.

Chaudhuri U, Forrest JR, Sastry K, et al.

Cureus 2025; (17(5)):e84405 doi:10.7759/cureus.84405.

Progress and Perspectives in Overlapping Primary Biliary Cholangitis and Autoimmune Hepatitis: A Comprehensive Review.

Qin X, Jin Z

Journal of gastrointestinal and liver diseases : JGLD 2025; (34(2)):241-249 doi:10.15403/jgld-6138.

Fulminant Primary Biliary Cholangitis-Autoimmune Hepatitis (PBC-AIH) Overlap Syndrome in a 27-Year-Old Woman With Childhood-Onset AIH: Steroid-Refractory Decompensation Necessitating Urgent Transplant Evaluation.

Said E, Tafesse Y, Elbenawi HR, et al.

Cureus 2025; (17(7)):e87519 doi:10.7759/cureus.87519.

Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitis.

Zhang GD, Attree C, Irani N, et al.

Internal medicine journal 2026; (56(6)):1026-1032 doi:10.1111/imj.70435.

When to Consider AIH-PBC Overlap Syndrome in the Pathology Report.

Chen W, Xu H, Wegermann K, Chen F

The American journal of surgical pathology 2026; (50(7)):814-824 doi:10.1097/PAS.0000000000002547.

Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome With Limited Systemic Sclerosis.

Vallejo Rico CF, Salazar Gonzalez GLA, Reyes Rueda J, et al.

Cureus 2026; (18(7)):e113525 doi:10.7759/cureus.113525.